Butamirate citrate (BC) is a type of short-acting β2-adrenergic agonist (SABA) used in the treatment of asthma and other respiratory conditions. It is a prodrug that is rapidly metabolized to its active form, salbutamol, upon administration. BC has been widely used in the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions due to its bronchodilatory properties. It is available in various formulations and delivery systems, including metered dose inhalers, nebulizers, and oral tablets.

 

Brand: BCM

 

Melting Point: 66-68°C

 

Solubility: Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)

 

Isomeric SMILES: CCC(C1=CC=CC=C1)C(=O)OCCOCCN(CC)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O  

 

InChIKey: JVKMHUAWFDGPTF-UHFFFAOYSA-N  

 

InChI: InChI=1S/C18H29NO3.C6H8O7/c1-4-17(16-10-8-7-9-11-16)18(20)22-15-14-21-13-12-19(5-2)6-3;7-3(8)1-6(13,5(11)12)2-4(9)10/h7-11,17H,4-6,12-15H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

 

Attribute
[CAS No.]	18109-81-4
[Formula]	C24H37NO10
[Molecular]	499.55100
[Chem Name]	2-[2-(diethylamino)ethoxy]ethyl 2-phenylbutanoate;2-hydroxypropane-1,2,3-tricarboxylic acid
[Synonym]	Butamirate Citrate
[Form]	White solid
[Storage]	Hygroscopic. Refrigerator. Under Inert Atmosphere
[EINECS]	242-006-8
[MDL No.]	MFCD00315222

Goods Tag